Equatorial Guinea vs Honduras: Prevalence rate of diabetes in adults
Equatorial Guinea
9.4
in 2014
Honduras
9.3
in 2014
Equatorial Guinea rank
76th
Honduras rank
78th
Prevalence rate of diabetes in adults over time
- Equatorial Guinea
- Honduras
How they compare
Equatorial Guinea currently reports 9.4 against 9.3 in Honduras, a difference of 0.1.
The two have swapped places 1 time across 35 shared years of data; in 1980 it was Honduras ahead.
Equatorial Guinea ranks 76th and Honduras ranks 78th of 190 countries.
Across the 4 decades both report, Equatorial Guinea averaged higher in 1 and Honduras in 3.
Head to head by decade
| Decade | Equatorial Guinea | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.08 | 4.28 | 1.2 | Honduras |
| 1990s | 4.43 | 5.62 | 1.19 | Honduras |
| 2000s | 6.94 | 7.31 | 0.37 | Honduras |
| 2010s | 8.9 | 8.82 | 0.08 | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Equatorial Guinea or Honduras?
- Equatorial Guinea, at 9.4 against 9.3 in Honduras as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Equatorial Guinea and Honduras?
- 0.1, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Honduras?
- 35 years are reported by both, from 1980 to 2014.
- How do Equatorial Guinea and Honduras rank globally for prevalence rate of diabetes in adults?
- Equatorial Guinea ranks 76th and Honduras ranks 78th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.